Inventor · disambiguated record
Marilyne Bourotte
Also filed as: BOUROTTE MARILYNE
7 granted patents·7 pending applications·0 citations·filing 2018–2025
71Inventor score
Top patents by PatentIndex Score
14 records- 0186US12403133B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2024·Granted Sep 2, 2025·0 cites·20 claims
- 0282US2025360115A1Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2025·Application pending·0 cites
- 0379US11903934B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2022·Granted Feb 20, 2024·0 cites·10 claims
- 0471US11344537B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2020·Granted May 31, 2022·0 cites·16 claims
- 0569US2024307385A1Novel compoundsBioVersys AG·Filed 2024·Application pending·0 cites
- 0662US2025213575A18-heterocyclic-3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives as anti-bacterialsBioVersys AG·Filed 2023·Application pending·0 cites
- 0762US2025376472A13-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivativesBioVersys AG·Filed 2023·Application pending·0 cites
- 0861US2025101039A1Rifamycin derivatives for the treatment of diseasesBioVersys AG·Filed 2023·Application pending·0 cites
- 0960US2025051356A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2022·Application pending·0 cites
- 1060US2025235434A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2023·Application pending·0 cites
- 1157US11969423B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Apr 30, 2024·0 cites·4 claims
- 1248US12509462B23-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivativesBioVersys AG·Filed 2019·Granted Dec 30, 2025·0 cites·18 claims
- 1345US11253499B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 22, 2022·0 cites·26 claims
- 1440US11254689B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 22, 2022·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Marilyne Bourotte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →